These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1626178)

  • 1. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
    Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
    Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relation between lipid-bound sialic acid in blood serum and plasma andin human tumors].
    Polívková J; Vosmiková K; Pospísil J; Poucková P
    Bratisl Lek Listy; 1992 May; 93(5):222-4. PubMed ID: 1393642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipid-bound sialic acid alterations in neoplastic diseases.
    Dwivedi C; Dixit M; Hardy RE
    Experientia; 1990 Jan; 46(1):91-4. PubMed ID: 2298288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid bound sialic acid in cancer patients.
    Salvagno L; Ferrazzi E; Sileni VC; Maggi S; Tredese F; Bedendo C; Russo MP; Fiorentino MV; Ceriotti G
    Tumori; 1985 Apr; 71(2):127-33. PubMed ID: 4002346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual and combined usefulness of lipid associated sialic acid, mucoid proteins and hexoses as tumor markers in breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Cancer Lett; 1990 Jun; 51(3):203-8. PubMed ID: 2161706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinoma.
    Patsner B; Mann WJ; Vissicchio M; Loesch M
    Gynecol Oncol; 1988 May; 30(1):98-103. PubMed ID: 2452774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
    Musset M; Mathé G; Reizenstein P
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):17-20. PubMed ID: 2663215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
    Dreyfuss AI; Clark JR; Andersen JW
    Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-bound sialic acid as a tumor marker.
    Dnistrian AM; Schwartz MK
    Ann Clin Lab Sci; 1983; 13(2):137-42. PubMed ID: 6859805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of lipid-bound sialic acid (LSA) as a tumor marker.
    López Sáez JJ; Senra-Varela A
    Int J Biol Markers; 1995; 10(3):174-9. PubMed ID: 8551061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer patients.
    Dnistrian AM; Schwartz MK
    Clin Chem; 1981 Oct; 27(10):1737-9. PubMed ID: 7285326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of serum lipid-bound sialic acid in bladder tumours.
    Oztokatli A; Ozkardeş H; Ovül E; Erol D
    Int Urol Nephrol; 1992; 24(2):125-9. PubMed ID: 1624255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of putative tumor markers for malignant melanoma.
    Reintgen DS; Cruse CW; Wells KE; Saba HI; Fabri PJ
    Ann Plast Surg; 1992 Jan; 28(1):55-9. PubMed ID: 1642407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer and family history: levels of lipid-associated sialic acid in plasma and absent family history of breast cancer in women who have breast tumors.
    Brower ST; Tartter P; Weiss S; Luderer AA; Lehrer S
    Mt Sinai J Med; 1995 Nov; 62(6):419-21. PubMed ID: 8692154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
    Yue K; Bian M; Zhu D; Liu W; Siu S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved procedure for determination of serum lipid-associated sialic acid: application for early diagnosis of colorectal cancer.
    Tautu C; Verazin G; Prorok JJ; Alhadeff JA
    J Natl Cancer Inst; 1988 Oct; 80(16):1333-7. PubMed ID: 3172258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total and lipid-bound serum sialic acid as markers for carcinoma of the uterine cervix.
    Vivas I; Spagnuolo L; Palacios P
    Gynecol Oncol; 1992 Aug; 46(2):157-62. PubMed ID: 1500016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement.
    Plucinsky MC; Riley WM; Prorok JJ; Alhadeff JA
    Cancer; 1986 Dec; 58(12):2680-5. PubMed ID: 3779617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of serum lipid-associated sialic acid concentration in dogs with neoplasms.
    Poli A; Arispici M; Camillo F; Corazza M
    Am J Vet Res; 1986 Mar; 47(3):607-9. PubMed ID: 3754401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker.
    Laganà A; Pardo-Martínez B; Marino A; Fago G; Bizzarri M
    Clin Chim Acta; 1995 Dec; 243(2):165-79. PubMed ID: 8747492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.